|
Home:
Educational
Supplement: Section 7
SELECT
PUBLICATIONS
Amadori D et
al. Disease-free survival advantage of adjuvant cyclophosphamide,
methotrexate and fluorouracil in patients with node-negative, rapidly
proliferating breast cancer: A randomized multicenter study.
J Clin Oncol 2000;18:3125-34. Abstract
Antman KH.
A critique of the eleven randomised trials of high-dose chemotherapy
for breast cancer. Eur J Cancer 2001;37(2):173-179. Abstract
Bang SM et
al. Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide,
methotrexate and 5-fluorouracil chemotherapy in premenopausal women
with axillary lymph node positive breast carcinoma. Cancer
2000;89:2521-6. Abstract
Benefit
of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive
breast cancer patients with poor prognostic factors: 5-year follow-up
results of French Adjuvant Study Group 05 randomized trial.
J Clin Oncol 2001;19:602-11. Abstract
Bontenbal M
et al. Value of estrogenic recruitment before chemotherapy: First
randomized trial in primary breast cancer. J Clin Oncol 2000;18:734-42.
Abstract
Braun S et
al. Lack of effect of adjuvant chemotherapy on the elimination
of single dormant tumor cells in bone marrow of high-risk breast
cancer patients. J Clin Oncol 2000;18:80-6. Abstract
Brezden CB
et al. Cognitive function in breast cancer patients receiving
adjuvant chemotherapy. J Clin Oncol 2000;18:2695-701.
Abstract
Buban GM et
al. Influences on oncologists’ adoption of new agents in
adjuvant chemotherapy of breast cancer. J Clin Oncol 2001;19:954-9.
Abstract
Chang J. Chemotherapy
dose reduction and delay in clinical practice. Evaluating the risk
to patient outcome in adjuvant chemotherapy for breast cancer.
Eur J Cancer 2000;36(Suppl 1):S11-14. Abstract
Chaplain G
et al. Increased risk of acute leukemia after adjuvant chemotherapy
for breast cancer: A population-based study. J Clin Oncol 2000;18:2836-42.
Abstract
Colleoni M
et al. Early start of adjuvant chemotherapy may improve treatment
outcome for premenopausal breast cancer patients with tumors not
expressing estrogen receptors. The International Breast Cancer Study
Group. J Clin Oncol 2000;18:584-90. Abstract
Crivellari
D et al. Burdens and benefits of adjuvant cyclophosphamide, methotrexate,
and fluorouracil and tamoxifen for elderly patients with breast
cancer: The International Breast Cancer Study Group Trial VII.
J Clin Oncol 2000;18:1412-22. Abstract
Demark-Wahnefried
W et al. Changes in weight, body composition and factors influencing
energy balance among premenopausal breast cancer patients receiving
adjuvant chemotherapy. J Clin Oncol 2001;19:2381-9. Abstract
Erselcan T
et al. Subclinical cardiotoxicity following adjuvant dose-escalated
FEC, high-dose chemotherapy or CMF in breast cancer. Br J
Cancer 2000;82(4):777-781. Abstract
Extermann M
et al. What threshold for adjuvant therapy in older breast cancer
patients? J Clin Oncol 2000;18:1709-17. Abstract
Fisher B et
al. Prognosis and treatment of patients with breast tumors of
one centimeter or less and negative axillary lymph nodes. J
Natl Cancer Inst 2001;93:112-20. Abstract
Fumoleau P
et al. Intensification of adjuvant chemotherapy: 5-year results
of a randomized trial comparing conventional doxorubicin and cyclophosphamide
with high-dose mitoxantrone and cyclophosphamide with filgrastim
in operable breast cancer with 10 or more involved axillary nodes.
J Clin Oncol 2001;19:612-20. Abstract
Hortobagyi
GN et al. Randomized trial of high-dose chemotherapy and blood
cell autografts for high-risk primary breast carcinoma. J
Natl Cancer Inst 2000;92:225-33. Abstract
Janicke F et
al. Randomized adjuvant chemotherapy trial in high-risk, lymph
node-negative breast cancer patients identified by urokinase-type
plasminogen activator and plasminogen activator inhibitor type 1.
J Natl Cancer Inst 2001;93:913-20. Abstract
Jansen SJ et
al. Patients’ preferences for adjuvant chemotherapy in early-stage
breast cancer: Is treatment worthwhile? Br J Cancer 2001;84(12):1577-1585.
Abstract
Joly F et al.
Long-term quality of life in premenopausal women with node-negative
localized breast cancer treated with or without adjuvant chemotherapy.
Br J Cancer 2000;83(5):577-582. Abstract
Lichtman SM,
Villani G. Chemotherapy in the elderly: Pharmacologic considerations.
Cancer Control 2000;7(6):548-56. Full-Text
Loprinzi CL,
Thome SD. Understanding the utility of adjuvant systemic therapy
for primary breast cancer. J Clin Oncol 2001;19:972- 9.
Abstract
Mayers C, Panzarella
T, Tannock IF. Analysis of the prognostic effects of inclusion
in a clinical trial and of myelosuppression on survival after adjuvant
chemotherapy for breast carcinoma. Cancer 2001;91:2246-57.
Abstract
Meinardi MT
et al. Prospective evaluation of early cardiac damage induced
by epirubicin-containing adjuvant chemotherapy and locoregional
radiotherapy in breast cancer patients. J Clin Oncol 2001;19:2746-53.
Abstract
Menard S et
al. Response to cyclophosphamide, methotrexate and fluorouracil
in lymph node-positive breast cancer according to HER2 overexpression
and other tumor biologic variables. J Clin Oncol 2001;19:329-35.
Abstract
Piccart MJ
et al. Phase III trial comparing two dose levels of epirubicin
combined with cyclophosphamide with cyclophosphamide, methotrexate
and fluorouracil in node-positive breast cancer. J Clin Oncol
2001;19:3103-10. Abstract
Pierga JY et
al. Effect of adjuvant chemotherapy on outcome in patients with
metastatic breast carcinoma treated with first-line doxorubicin-containing
chemotherapy. Cancer 2001;91:1079-89. Abstract
Poikonen P
et al. Prognostic effect of amenorrhoea and elevated serum gonadotropin
levels induced by adjuvant chemotherapy in premenopausal node-positive
breast cancer patients. Eur J Cancer 2000;36(1):43-48.
Abstract
Ravdin PM et
al. Computer program to assist in making decisions about adjuvant
therapy for women with early breast cancer. J Clin Oncol
2001;19:980-91. Abstract
Shapiro CL
et al. Ovarian failure after adjuvant chemotherapy is associated
with rapid bone loss in women with early-stage breast cancer.
J Clin Oncol 2001;19:3306-11. Abstract
Wolff AC, Davidson
NE. Primary systemic therapy in operable breast cancer. J
Clin Oncol 2000;18:1558-69. Abstract
Top
OTHER
RESOURCES
NCI Bibliography
of Adjuvant Therapy for Breast Cancer: July 1995-July 2000 Weblink
Mayo Clinic’s
webtool for determining adjuvant breast cancer treatment benefits
Weblink
Top
Additional
Sections:
1 | 2
| 3 | 4
| 5 | 6
| 7 | 8
| 9 | 10
| 11 | 12
|
|
